FDA panel to discuss Pradaxa

FDA's Cardiovascular and Renal Drugs Advisory Committee will meet on Sept. 20 to discuss an NDA for Pradaxa dabigatran from Boehringer Ingelheim GmbH (Ingelheim, Germany) to prevent stroke in patients...